Official recall notice

FDA DrugClass IINotable

FDA Recall: Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-fiv

Recall date
2026-07-29
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Presence of Particulate Matter: Hair was found in products

Product description

Presence of Particulate Matter: Hair was found in products

Affected products

Lot #: 6133436, Exp. Date 10/2028

Verify with the official notice →
Share:

Related Recalls

2026-07-29 · FDA_DRUG
FDA Recall: Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx o
Fresenius Kabi USA, LLC
2026-07-29 · FDA_DRUG
FDA Recall: Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vial
Fresenius Kabi USA, LLC
2026-07-29 · FDA_DRUG
FDA Recall: Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vial
Fresenius Kabi USA, LLC
2026-06-17 · FDA_DRUG
FDA Recall: Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL
Fresenius Kabi USA, LLC